News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tuberculosis Diagnostics Company Oxford Immunotec Limited Sets Terms For $75 Million IPO


11/11/2013 8:07:35 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Oxford Immunotec Global, which sells diagnostic tests for latent Tuberculosis infection, announced terms for its IPO on Friday. The Abingdon, United Kingdom-based company plans to raise $75 million by offering 5.4 million shares at a price range of $13 to $15. At the midpoint of the proposed range, Oxford Immunotec would command a fully diluted market value of $247 million.

Help employers find you! Check out all the jobs and post your resume.

Read at Nasdaq
Read at News Release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES